Keyphrases
Semicarbazide-sensitive Amine Oxidase
100%
ERK5
70%
ABTL0812
50%
Monoamine Oxidase A (MAO-A)
42%
Amine Oxidase
36%
Monoamine Oxidase B (MAO-B)
35%
Benzylamine
31%
Oxidase Activity
31%
Mammalian Target of Rapamycin (mTOR)
30%
Methylamine
28%
Anticancer Drugs
26%
TRIB3
26%
Dopamine
25%
Endoplasmic Reticulum Stress (ER stress)
24%
Mitogen-activated Protein Kinase
24%
Autophagy
23%
Bovine Lung
22%
Cancer Cells
19%
Overexpression
17%
Endometrial Cancer
16%
Metabolism
16%
Kinase Activity
15%
Liver Kinase B1 (LKB1)
15%
Phosphorylation
15%
Pyrimido
14%
In Cancer
14%
Vmax
14%
Caenorhabditis Elegans
14%
Membrane Binding
13%
Nuclear Translocation
13%
Therapeutic Potential
13%
MAPK7
13%
Glucose Transport
13%
Bovine Retina
13%
PDK1
13%
Autophagy Inducer
13%
Cancer Cell Death
13%
Cancer Cell Proliferation
12%
Cytotoxic Autophagy
12%
Oxidative Deamination
11%
Pseudokinase
10%
Microsomes
10%
Rac1
9%
Apoptosis
9%
Clinical Trials
9%
Dialysis
9%
Specific Inhibitor
9%
Tumor Growth
9%
Benzo
9%
Selective Inhibitor
9%
Biochemistry, Genetics and Molecular Biology
Amine Oxidase (Copper-Containing)
81%
Phosphotransferase
54%
Kinase
54%
Enzyme
45%
Cancer Cell
37%
Autophagy
26%
Mitogen-Activated Protein Kinase
25%
Cell Proliferation
20%
Monoamine Oxidase A
20%
Monoamine Oxidase
18%
Signal Transduction
17%
Isoform
15%
Cell Death
14%
Endoplasmic Reticulum Stress
14%
Blood Plasma
14%
Protein Kinases
13%
Hsp90
13%
MAPK7
13%
Caenorhabditis Elegans
13%
Promoter Region
13%
Glucose Transport
13%
Monoamine Oxidase B
11%
Clinical Trial
11%
Amine Oxidase
10%
Growth Factor
10%
Anticancer
10%
Tumor Progression
10%
Oxidative Deamination
10%
Metabolic Pathway
9%
Adipocyte
9%
Cell Survival
8%
Mammalian Target of Rapamycin
8%
Genetics
8%
C-Terminus
8%
Downregulation
7%
Ubiquitin
7%
Lipid
7%
Mechanistic Target of Rapamycin
7%
Pharmacodynamics
7%
Transcription
7%
Unfolded Protein Response
7%
Overall Survival
7%
Chimeric Protein
7%
Mitochondrion
7%
Binding Site
6%
Peptide Sequence
6%
Carcinogenesis
6%
Histone H3
6%
Cell Cycle
6%
Somatic Mutation
6%